🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Rivaroxaban 2.5 MG Oral Tablet [Xarelto]

    The University of Hong Kong

    Atherosclerosis, Coronary

    approved small molecule completed

    1 trial

  2. Rivaroxaban 2.5 mg

    Second Xiangya Hospital of Central South University

    Acute Coronary Syndrome

    approved small molecule completed

    1 trial

  3. Rucacuzumab plus standard therapy

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke AIS

    approved small molecule active

    1 trial

  4. SEMAGLUTIDE, SEMAGLUTIDE, INSULIN GLARGINE, DAPAGLIFLOZIN

    Fondazione Telethon ETS

    type 2 diabetes

    approved small molecule active

    1 trial

  5. SGLT2 inhibitor

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    approved small molecule active

    1 trial

  6. SGLT2 inhibitor (Empagliflozin 25 MG)

    Hospital Authority, Hong Kong

    Type2 Diabetes

    approved small molecule active

    1 trial

  7. SODIUM CHLORIDE, Ondansetron Morningside 4 mg orodispergeerbare tabletten, Ondansetron 2 mg/ml Solution for Injection, Ketanest® S 5 mg/ml - Ampullen

    Shanghai Reinovax Biologics Co.,LTD

    Endometriosis

    approved small molecule active

    1 trial

  8. Sabin-IPV and DTaP

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  9. Sabin-IPV+bOPV+bOPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  10. Sarilumab

    Regeneron UK Limited

    Rheumatoid Arthritis

    approved small molecule terminated

    8 trials

  11. Sarilumab

    Regeneron UK Limited

    Polymyalgia Rheumatica

    approved small molecule active

    1 trial

  12. Satralizumab 120 mg

    Hoffmann-La Roche

    Neuromyelitis Optica Spectrum Disorder

    approved small molecule terminated

    1 trial

  13. Secukinumab s.c. injection

    Novartis Pharmaceuticals

    Autoimmunity, Inflammation

    approved mab active

    1 trial

  14. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intra-abdominal and Intrapelvic Surgery

    approved small molecule completed

    1 trial

  15. Sham Injection

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  16. Sitagliptin

    Chen Suning

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  17. Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets

    The George Institute

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  18. Sodium Chloride Fresenius Kabi Italia 0,9 % Solution for infusion, MabThera 500 mg concentrate for solution for infusion

    Disc Medicine

    Systemic sclerosis

    approved small molecule active

    1 trial

  19. Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable

    Disc Medicine

    Fibrous dysplasia/McCune-Albright syndrome

    approved small molecule active

    1 trial

  20. Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

    BRIGHT MINDS BIOSCIENCES INC.

    HEPATITIS C (HCV)

    approved small molecule active

    1 trial

  21. Softacort 3,35 mg/ml colirio en solución en envases unidosis

    Laboratorios Tillomed Spain S.L.U

    Dry Eye and Meibomian Gland Dysfunction

    approved small molecule active

    1 trial

  22. Solriamfetol Oral Tablet

    Axsome Therapeutics

    Excessive Sleepiness

    approved small molecule terminated

    1 trial

  23. Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete

    Novo Nordisk A/S

    Hyperlipidaemia

    approved small molecule active

    1 trial

  24. Sovaldi 400 mg film-coated tablets

    Disc Medicine

    Healthy volunteers

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources